invasive Meningococcal Infection caused by Neisseria meningitidis serogroup W-135 (DBCOND0093732)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine	A conjugate vaccine used to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.	No drug targets
Meningococcal polysaccharide vaccine group W-135	Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup W-135. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and...	No drug targets
Neisseria meningitidis group A capsular polysaccharide tetanus toxoid conjugate antigen	This antigen is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y. It is approved for use in individuals 10...	No drug targets
Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen	Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine...	No drug targets

Clinical Trials

Not Available